188 related articles for article (PubMed ID: 30482543)
1. Microinvasive breast carcinoma: An analysis from ten Senonetwork Italia breast centres.
Costarelli L; Cianchetti E; Corsi F; Friedman D; Ghilli M; Lacaria M; Menghini L; Murgo R; Ponti A; Rinaldi S; Del Turco MR; Taffurelli M; Tinterri C; Tomatis M; Fortunato L
Eur J Surg Oncol; 2019 Feb; 45(2):147-152. PubMed ID: 30482543
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic analysis of a large series of microinvasive breast cancers.
Lillemoe TJ; Tsai ML; Swenson KK; Susnik B; Krueger J; Harris K; Rueth N; Grimm E; Leach JW
Breast J; 2018 Jul; 24(4):574-579. PubMed ID: 29476574
[TBL] [Abstract][Full Text] [Related]
3. Casting-type calcifications with invasion and high-grade ductal carcinoma in situ: a more aggressive disease?
Zunzunegui RG; Chung MA; Oruwari J; Golding D; Marchant DJ; Cady B
Arch Surg; 2003 May; 138(5):537-40. PubMed ID: 12742959
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
[TBL] [Abstract][Full Text] [Related]
5. Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma.
Moriya T; Silverberg SG
Cancer; 1994 Dec; 74(11):2972-8. PubMed ID: 7954261
[TBL] [Abstract][Full Text] [Related]
6. [Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications].
Modesto A; Gandy C; Mery E; Filleron T; Massabeau C; Izar F; Charitansky H; Roché H; de Lafontan B
Cancer Radiother; 2014 Mar; 18(2):107-10. PubMed ID: 24637020
[TBL] [Abstract][Full Text] [Related]
7. Microinvasive breast carcinoma carries an excellent prognosis regardless of the tumor characteristics.
Shatat L; Gloyeske N; Madan R; O'Neil M; Tawfik O; Fan F
Hum Pathol; 2013 Dec; 44(12):2684-9. PubMed ID: 24071019
[TBL] [Abstract][Full Text] [Related]
8. Could breast multiparametric MRI discriminate between pure ductal carcinoma in situ and microinvasive carcinoma?
Rizzo V; Cicciarelli F; Galati F; Moffa G; Maroncelli R; Pasculli M; Pediconi F
Acta Radiol; 2024 Jun; 65(6):565-574. PubMed ID: 38196268
[TBL] [Abstract][Full Text] [Related]
9. Clinic-Pathological Features of Breast Ductal Carcinoma
Zheng J; Zhou T; Li F; Shi J; Zhang L
Cancer Invest; 2020 Feb; 38(2):113-121. PubMed ID: 31939679
[No Abstract] [Full Text] [Related]
10. Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
Dillon MF; McDermott EW; Quinn CM; O'Doherty A; O'Higgins N; Hill AD
J Surg Oncol; 2006 Jun; 93(7):559-63. PubMed ID: 16705731
[TBL] [Abstract][Full Text] [Related]
11. Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation.
Parikh RR; Haffty BG; Lannin D; Moran MS
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):7-13. PubMed ID: 20950955
[TBL] [Abstract][Full Text] [Related]
12. Risk factor for axillary lymph node metastases in microinvasive breast cancer.
Ko BS; Lim WS; Kim HJ; Yu JH; Lee JW; Kwan SB; Lee YM; Son BH; Gong GY; Ahn SH
Ann Surg Oncol; 2012 Jan; 19(1):212-6. PubMed ID: 21633867
[TBL] [Abstract][Full Text] [Related]
13. The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ.
Yoon GY; Choi WJ; Cha JH; Shin HJ; Chae EY; Kim HH
BMC Med Imaging; 2020 Aug; 20(1):95. PubMed ID: 32787871
[TBL] [Abstract][Full Text] [Related]
14. Comparison of breast ductal carcinoma in situ and ductal carcinoma in situ with microinvasion, and analysis of axillary lymph node metastasis.
Zhang G; Li C; Tian G; Cheng X; Li Y; Ma L
Medicine (Baltimore); 2020 Dec; 99(52):e23593. PubMed ID: 33350734
[TBL] [Abstract][Full Text] [Related]
15. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast.
van la Parra RF; Ernst MF; Barneveld PC; Broekman JM; Rutten MJ; Bosscha K
Eur J Surg Oncol; 2008 Jun; 34(6):631-5. PubMed ID: 17851019
[TBL] [Abstract][Full Text] [Related]
16. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.
Maffuz A; Barroso-Bravo S; Nájera I; Zarco G; Alvarado-Cabrero I; Rodríguez-Cuevas SA
J Exp Clin Cancer Res; 2006 Jun; 25(2):223-7. PubMed ID: 16918134
[TBL] [Abstract][Full Text] [Related]
17. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.
Han JS; Molberg KH; Sarode V
Breast J; 2011; 17(3):223-9. PubMed ID: 21545433
[TBL] [Abstract][Full Text] [Related]
18. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
Padmore RF; Fowble B; Hoffman J; Rosser C; Hanlon A; Patchefsky AS
Cancer; 2000 Mar; 88(6):1403-9. PubMed ID: 10717623
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary Shared Decision Making in the Management of Ductal Carcinoma In Situ of the Breast.
Parikh P; Pockaj B; Wasif N; Halyard M; Wong W; Kosiorek HE; Dueck AC; Gray R
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(0 3):S516-21. PubMed ID: 25986869
[TBL] [Abstract][Full Text] [Related]
20. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].
Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J
Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]